Mohamed A. Hessien

Tanda, GH 31527, Egypt

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 20 publications

Insights into antiviral activity of chlorpromazine against RNA viruses: Molecular docking, ADME profile, and semi-in vivo study.

Insights into antiviral activity of chlorpromazine against RNA viruses: Molecular docking, ADME profile, and semi-in vivo study.

Journal: Journal of virological methods

Published: September 16, 2025

Vasopressin boosts the antiproliferative effect of dynasore and wortmannin in triple-negative breast cancer cells.

Vasopressin boosts the antiproliferative effect of dynasore and wortmannin in triple-negative breast cancer cells.

Journal: Medical oncology (Northwood, London, England)

Published: September 04, 2025

Histone Acetylation Retards the Adipogenic Differentiation of Human Umbilical Cord - Mesenchymal Stem Cells: A Clue for Anti-obesity Approach?

Histone Acetylation Retards the Adipogenic Differentiation of Human Umbilical Cord - Mesenchymal Stem Cells: A Clue for Anti-obesity Approach?

Journal: Current pharmaceutical design

Published: April 18, 2025

Influence of ZnO and TiO2 additions on structural, physical, and electrical properties of LaCo0.3Mn0.7O3 perovskite.

Influence of ZnO and TiO2 additions on structural, physical, and electrical properties of LaCo0.3Mn0.7O3 perovskite.

Journal: Scientific reports

Published: January 08, 2025

Dexamethasone-boosted mesenchymal stem cell secretome: insight into hepatic protection.

Dexamethasone-boosted mesenchymal stem cell secretome: insight into hepatic protection.

Journal: BMC biotechnology

Published: December 09, 2024

Author Correction: Inhibition of Drp1 orchestrates the responsiveness of breast cancer cells to paclitaxel but insignificantly relieves paclitaxel‑related ovarian damage in mice.

Author Correction: Inhibition of Drp1 orchestrates the responsiveness of breast cancer cells to paclitaxel but insignificantly relieves paclitaxel‑related ovarian damage in mice.

Journal: Scientific reports

Published: April 29, 2024

Impregnation of mesenchymal stem cell conditioned media with wortmannin enhanced its antiproliferative effect in breast cancer cells via PI3K/Akt/mTOR pathway.

Impregnation of mesenchymal stem cell conditioned media with wortmannin enhanced its antiproliferative effect in breast cancer cells via PI3K/Akt/mTOR pathway.

Journal: BMC research notes

Published: March 26, 2024

Novel insight into mitochondrial dynamin-related protein-1 as a new chemo-sensitizing target in resistant cancer cells.

Novel insight into mitochondrial dynamin-related protein-1 as a new chemo-sensitizing target in resistant cancer cells.

Journal: Bioorganic chemistry

Published: February 18, 2024

Molecular docking as a tool for the discovery of novel insight about the role of acid sphingomyelinase inhibitors in SARS- CoV-2 infectivity.

Molecular docking as a tool for the discovery of novel insight about the role of acid sphingomyelinase inhibitors in SARS- CoV-2 infectivity.

Journal: BMC public health

Published: October 24, 2023

Conservative Hypomethylation of Mesenchymal Stem Cells and Their Secretome Restored the Follicular Development in Cisplatin-Induced Premature Ovarian Failure Mice.

Conservative Hypomethylation of Mesenchymal Stem Cells and Their Secretome Restored the Follicular Development in Cisplatin-Induced Premature Ovarian Failure Mice.

Journal: Reproductive sciences (Thousand Oaks, Calif.)

Published: September 06, 2023

The emerging roles of sphingosine 1-phosphate and SphK1 in cancer resistance: a promising therapeutic target.

The emerging roles of sphingosine 1-phosphate and SphK1 in cancer resistance: a promising therapeutic target.

Journal: Cancer cell international

Published: August 19, 2023

Inhibition of Drp1 orchestrates the responsiveness of breast cancer cells to paclitaxel but insignificantly relieves paclitaxel-related ovarian damage in mice.

Inhibition of Drp1 orchestrates the responsiveness of breast cancer cells to paclitaxel but insignificantly relieves paclitaxel-related ovarian damage in mice.

Journal: Scientific reports

Published: July 08, 2023

Showing 1-12 of 20

Last Updated: 09/26/2026